Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine

BACKGROUND: Chronic migraine is a neurological condition with a large individual and socioeconomic burden of disease. The recently completed Phase III REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) clinical development program established the efficacy and safety of onabotulinumtoxinA as...

Descripción completa

Detalles Bibliográficos
Autores principales: Blumenfeld, Andrew M., Aurora, Sheena K., Laranjo, Karen, Papapetropoulos, Spyros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489131/
https://www.ncbi.nlm.nih.gov/pubmed/26133547
http://dx.doi.org/10.1186/s12883-015-0353-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489131/
https://www.ncbi.nlm.nih.gov/pubmed/26133547
http://dx.doi.org/10.1186/s12883-015-0353-x

Ejemplares similares